2025 Asia-Pacific Adult Vaccine Market Revenue Opportunities Report
Description
The 2025 Asia-Pacific Adult Vaccine Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Adult Vaccine Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Adult Vaccine Market in the Asia-Pacific region include GlaxoSmithKline plc (GSK), Pfizer Inc., Bharat Biotech, and Serum Institute of India Pvt. Ltd. GSK offers a broad vaccine portfolio covering hepatitis, influenza, HPV, and meningitis, leveraging strong R&D and distribution in Asia-Pacific. Pfizer is noted for its COVID-19 vaccine Comirnaty and extensive manufacturing and distribution networks. Bharat Biotech, an Indian multinational, is recognized for vaccines like Covaxin (COVID-19) and Typbar TCV (typhoid), contributing significantly to regional supply. Serum Institute of India, also based in India, is a major manufacturer exporting vaccines worldwide, including to Asia-Pacific countries.
These companies benefit from rapidly growing demand driven by large populations in India, China, and Japan, improving healthcare infrastructure, and rising income levels. Government initiatives like India’s Mission Indradhanush aim to increase immunization coverage, further expanding market opportunities. Additionally, advancements in vaccine technology, including mRNA and recombinant vaccines, enhance efficacy and safety, attracting investment. The Asia-Pacific region is expected to be the fastest-growing adult vaccines market, with these leading players leveraging both local manufacturing and global partnerships to meet the increasing demand.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Adult Vaccine Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Adult Vaccine Market in the Asia-Pacific region include GlaxoSmithKline plc (GSK), Pfizer Inc., Bharat Biotech, and Serum Institute of India Pvt. Ltd. GSK offers a broad vaccine portfolio covering hepatitis, influenza, HPV, and meningitis, leveraging strong R&D and distribution in Asia-Pacific. Pfizer is noted for its COVID-19 vaccine Comirnaty and extensive manufacturing and distribution networks. Bharat Biotech, an Indian multinational, is recognized for vaccines like Covaxin (COVID-19) and Typbar TCV (typhoid), contributing significantly to regional supply. Serum Institute of India, also based in India, is a major manufacturer exporting vaccines worldwide, including to Asia-Pacific countries.
These companies benefit from rapidly growing demand driven by large populations in India, China, and Japan, improving healthcare infrastructure, and rising income levels. Government initiatives like India’s Mission Indradhanush aim to increase immunization coverage, further expanding market opportunities. Additionally, advancements in vaccine technology, including mRNA and recombinant vaccines, enhance efficacy and safety, attracting investment. The Asia-Pacific region is expected to be the fastest-growing adult vaccines market, with these leading players leveraging both local manufacturing and global partnerships to meet the increasing demand.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
